UK's Haleon falls after forecasting FY organic revenue growth below target

HALEON

25/02/2026 08:41

** Shares of British consumer healthcare group Haleon HLN.L down 3.7% at 390.7 pence

** Co expects FY organic revenue growth to be 3%-5%, below its medium-term forecast of 4%-6%

** Reports Q4 organic sales growth of 2.1%, below Jefferies' estimate of 3.1%

** Says consumer environment remains challenging near-term

** Expects weak cold and flu season to have c.150 bps impact in Q4 and c.40 bps for full year

** HLN up ~8.24% this year, as of last close

 (Reporting by Megha Kumari)

 ((Megha.Kumari@thomsonreuters.com;))